Company: BIAF
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024163
Chunk: 101

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 1A
Chunk 101
---
.

Based
on the provisions for determining beneficial ownership in accordance with Rule 13d-3 and Item 403 of Regulation S-K under the Exchange
Act, our officers and directors own or exercise control of approximately 46.13% of the voting power of our outstanding Common Stock.
As a result, investors may be prevented from affecting matters involving our Company, including:

    ●
    the composition of our
    Board and, through it, any determination with respect to our business direction and policies, including the appointment and removal
    of officers;

    ●
    any determinations with
    respect to mergers or other business combinations;

    ●
    our acquisition or disposition
    of assets; and

    ●
    our corporate financing
    activities.

Furthermore,
this concentration of voting power could have the effect of delaying, deterring, or preventing a change of control or other business
combination that might otherwise be beneficial to our stockholders. This significant concentration of share ownership may also adversely
affect the trading price for our Common Stock because investors may perceive disadvantages in owning stock in a company that is controlled
by a small number of stockholders.

ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM
3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM
4. MINE SAFETY DISCLOSURES.

Not
applicable.

ITEM
5. OTHER INFORMATION.

Rule
10b5-1 Trading Plans

During
the fiscal quarter ended June 30, 2025, none of the Company’s directors or executive officers adopted or terminated any contract,
instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions
of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

31

ITEM
6. EXHIBITS.

    Exhibit
    No.
     
    Title
    of Document

    31.1*
     
    Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002
  
    31.2*
     
    Certification of Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002
  
    32.1**
     
    Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of